@papich_krug: #юмор #кружки #приколы

Круглый Угар

Open In TikTok:

Region: UA

Tuesday 01 October 2024 06:17:35 GMT

1449

87

0

6

Music

Download

No Watermark .mp4 (5.89MB) No Watermark(HD) .mp4 (5.89MB) Watermark .mp4 (0MB) Music .mp3

Comments

There are no more comments for this video.

To see more videos from user @papich_krug, please go to the Tikwm homepage.

Other Videos

A very common question I get asked often is how effective are the weight loss drugs (specifically GLP-1 agonists - Ozempic and Wegovy) in patients with breast cancer. This is a great study being presented at @ascocancer by Dr. Sherry Shen, Dr. Neil Iyengar and colleagues that looked at this question! Average weight change is 5% (about 10 lbs) at 12 months of GLP-1 agonist use. Breast cancer treatments (and premature menopause that often results from treatment) can cause metabolic dysfunction and weight gain. People can do all the “right” lifestyle behaviors and still not lose a single pound as a result. These drugs can be a very useful tool - always in conjunction with diet and exercise. They are not right for everyone but can be an option for some! We must also remember that the benefit of the weight loss medications go beyond weight loss as they improve insulin resistance, can reduce risk of cardiovascular disease, reduce risk of obesity related cancers and more. Yes, these meds have a risk of thyroid cancer but it is very low! A separate study being presented at this year’s ASCO meeting found the incident of thyroid cancer in thousands of people on these medications was 0.35%. Let me know your questions. If you have been on these medications, I would love to hear your experience as that may inspire others. #weightloss #weightlossmedication #ozempic #wegovy #breastcancer #prematuremenopause #menopause #oncologist #asco24

A very common question I get asked often is how effective are the weight loss drugs (specifically GLP-1 agonists - Ozempic and Wegovy) in patients with breast cancer. This is a great study being presented at @ascocancer by Dr. Sherry Shen, Dr. Neil Iyengar and colleagues that looked at this question! Average weight change is 5% (about 10 lbs) at 12 months of GLP-1 agonist use. Breast cancer treatments (and premature menopause that often results from treatment) can cause metabolic dysfunction and weight gain. People can do all the “right” lifestyle behaviors and still not lose a single pound as a result. These drugs can be a very useful tool - always in conjunction with diet and exercise. They are not right for everyone but can be an option for some! We must also remember that the benefit of the weight loss medications go beyond weight loss as they improve insulin resistance, can reduce risk of cardiovascular disease, reduce risk of obesity related cancers and more. Yes, these meds have a risk of thyroid cancer but it is very low! A separate study being presented at this year’s ASCO meeting found the incident of thyroid cancer in thousands of people on these medications was 0.35%. Let me know your questions. If you have been on these medications, I would love to hear your experience as that may inspire others. #weightloss #weightlossmedication #ozempic #wegovy #breastcancer #prematuremenopause #menopause #oncologist #asco24

#stitch với @nnti_789 #vanvatbietnoi gớm quá má ơi 😱😱😱#LearnOnTikTok #xuhuong #trending #hai

#stitch với @nnti_789 #vanvatbietnoi gớm quá má ơi 😱😱😱#LearnOnTikTok #xuhuong #trending #hai

A very common question I get asked often is how effective are the weight loss drugs (specifically GLP-1 agonists - Ozempic and Wegovy) in patients with breast cancer. This is a great study being presented at @ascocancer by Dr. Sherry Shen, Dr. Neil Iyengar and colleagues that looked at this question! Average weight change is 5% (about 10 lbs) at 12 months of GLP-1 agonist use. Breast cancer treatments (and premature menopause that often results from treatment) can cause metabolic dysfunction and weight gain. People can do all the “right” lifestyle behaviors and still not lose a single pound as a result. These drugs can be a very useful tool - always in conjunction with diet and exercise. They are not right for everyone but can be an option for some! We must also remember that the benefit of the weight loss medications go beyond weight loss as they improve insulin resistance, can reduce risk of cardiovascular disease, reduce risk of obesity related cancers and more. Yes, these meds have a risk of thyroid cancer but it is very low! A separate study being presented at this year’s ASCO meeting found the incident of thyroid cancer in thousands of people on these medications was 0.35%. Let me know your questions. If you have been on these medications, I would love to hear your experience as that may inspire others. #weightloss #weightlossmedication #ozempic #wegovy #breastcancer #prematuremenopause #menopause #oncologist #asco24

A very common question I get asked often is how effective are the weight loss drugs (specifically GLP-1 agonists - Ozempic and Wegovy) in patients with breast cancer. This is a great study being presented at @ascocancer by Dr. Sherry Shen, Dr. Neil Iyengar and colleagues that looked at this question! Average weight change is 5% (about 10 lbs) at 12 months of GLP-1 agonist use. Breast cancer treatments (and premature menopause that often results from treatment) can cause metabolic dysfunction and weight gain. People can do all the “right” lifestyle behaviors and still not lose a single pound as a result. These drugs can be a very useful tool - always in conjunction with diet and exercise. They are not right for everyone but can be an option for some! We must also remember that the benefit of the weight loss medications go beyond weight loss as they improve insulin resistance, can reduce risk of cardiovascular disease, reduce risk of obesity related cancers and more. Yes, these meds have a risk of thyroid cancer but it is very low! A separate study being presented at this year’s ASCO meeting found the incident of thyroid cancer in thousands of people on these medications was 0.35%. Let me know your questions. If you have been on these medications, I would love to hear your experience as that may inspire others. #weightloss #weightlossmedication #ozempic #wegovy #breastcancer #prematuremenopause #menopause #oncologist #asco24

A very common question I get asked often is how effective are the weight loss drugs (specifically GLP-1 agonists - Ozempic and Wegovy) in patients with breast cancer. This is a great study being presented at @ascocancer by Dr. Sherry Shen, Dr. Neil Iyengar and colleagues that looked at this question! Average weight change is 5% (about 10 lbs) at 12 months of GLP-1 agonist use. Breast cancer treatments (and premature menopause that often results from treatment) can cause metabolic dysfunction and weight gain. People can do all the “right” lifestyle behaviors and still not lose a single pound as a result. These drugs can be a very useful tool - always in conjunction with diet and exercise. They are not right for everyone but can be an option for some! We must also remember that the benefit of the weight loss medications go beyond weight loss as they improve insulin resistance, can reduce risk of cardiovascular disease, reduce risk of obesity related cancers and more. Yes, these meds have a risk of thyroid cancer but it is very low! A separate study being presented at this year’s ASCO meeting found the incident of thyroid cancer in thousands of people on these medications was 0.35%. Let me know your questions. If you have been on these medications, I would love to hear your experience as that may inspire others. #weightloss #weightlossmedication #ozempic #wegovy #breastcancer #prematuremenopause #menopause #oncologist #asco24

A very common question I get asked often is how effective are the weight loss drugs (specifically GLP-1 agonists - Ozempic and Wegovy) in patients with breast cancer. This is a great study being presented at @ascocancer by Dr. Sherry Shen, Dr. Neil Iyengar and colleagues that looked at this question! Average weight change is 5% (about 10 lbs) at 12 months of GLP-1 agonist use. Breast cancer treatments (and premature menopause that often results from treatment) can cause metabolic dysfunction and weight gain. People can do all the “right” lifestyle behaviors and still not lose a single pound as a result. These drugs can be a very useful tool - always in conjunction with diet and exercise. They are not right for everyone but can be an option for some! We must also remember that the benefit of the weight loss medications go beyond weight loss as they improve insulin resistance, can reduce risk of cardiovascular disease, reduce risk of obesity related cancers and more. Yes, these meds have a risk of thyroid cancer but it is very low! A separate study being presented at this year’s ASCO meeting found the incident of thyroid cancer in thousands of people on these medications was 0.35%. Let me know your questions. If you have been on these medications, I would love to hear your experience as that may inspire others. #weightloss #weightlossmedication #ozempic #wegovy #breastcancer #prematuremenopause #menopause #oncologist #asco24

Liệu rằng nghèo có ohair là cái tội ?#CapCut #xuhuong #varil #fyl #xuhuongtiktok #chill

Liệu rằng nghèo có ohair là cái tội ?#CapCut #xuhuong #varil #fyl #xuhuongtiktok #chill

250328 트레저 팬콘 첫콘 YELLOW💛 #TREASURE #트레저 #츼현석 #박지훈 #요시 #김준규 #윤재혁 #아사히 #김도영 #하루토 #박정우 #소정환

250328 트레저 팬콘 첫콘 YELLOW💛 #TREASURE #트레저 #츼현석 #박지훈 #요시 #김준규 #윤재혁 #아사히 #김도영 #하루토 #박정우 #소정환

About

Robot

Legal

Privacy Policy